MARKET

IMUX

IMUX

Immunic Inc
NASDAQ
0.9400
-0.0347
-3.56%
After Hours: 0.9497 +0.0097 +1.03% 19:59 02/20 EST
OPEN
0.9500
PREV CLOSE
0.9747
HIGH
0.9601
LOW
0.8981
VOLUME
2.54M
TURNOVER
--
52 WEEK HIGH
1.390
52 WEEK LOW
0.5062
MARKET CAP
113.07M
P/E (TTM)
-1.1241
1D
5D
1M
3M
1Y
5Y
1D
Immunic Inc. Announces Special Stockholders Meeting in Preliminary Proxy Statement
Reuters · 1d ago
What Does the Market Think About Immunic Inc?
Benzinga · 2d ago
Immunic Raises $200 Million in Private Placement Financing
Reuters · 4d ago
Immunic Issues Warrants in $400 Million Private Placement
Reuters · 4d ago
EQS-NEWS: IMMUNIC ANNOUNCES CLOSING OF OVERSUBSCRIBED PRIVATE PLACEMENT FINANCING
Reuters · 4d ago
Press Release: Immunic Announces Closing of Oversubscribed Private Placement Financing
Dow Jones · 4d ago
Weekly Report: what happened at IMUX last week (0209-0213)?
Weekly Report · 6d ago
Why Is Immunic Stock Soaring Friday?
Benzinga · 02/13 18:55
More
About IMUX
Immunic, Inc. is a biotechnology company developing a clinical pipeline of selective oral immunology therapies focused on treating chronic inflammatory and autoimmune diseases. The Company is engaged in pursuing clinical development of programs, which include the vidofludimus calcium (IMU-838) program, which is in Phase III clinical development for patients with relapsing multiple sclerosis (RMS), and which has shown therapeutic activity in Phase II clinical trials in patients suffering from relapsing-remitting MS, progressive MS and moderate-to-severe ulcerative colitis; the IMU-856 program, which is targeted to regenerate bowel epithelium and restore intestinal barrier function, which could potentially be applicable in numerous gastrointestinal diseases, such as celiac disease, inflammatory bowel disease, Graft-versus-Host-Disease and weight management, and the IMU-381 program, which is a molecule being developed to specifically address the needs of gastrointestinal diseases.

Webull offers Immunic Inc stock information, including NASDAQ: IMUX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, IMUX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading IMUX stock methods without spending real money on the virtual paper trading platform.